Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics

The potential impact of using human genetic data linked to longitudinal electronic medical records on drug development is extraordinary; however, the practical application of these data necessitates some organizational innovations. Vanderbilt has created resources such as an easily queried database...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Assay and drug development technologies 2017-04, Vol.15 (3), p.113-119
Hauptverfasser:	Pulley, Jill M, Shirey-Rice, Jana K, Lavieri, Robert R, Jerome, Rebecca N, Zaleski, Nicole M, Aronoff, David M, Bastarache, Lisa, Niu, Xinnan, Holroyd, Kenneth J, Roden, Dan M, Skaar, Eric P, Niswender, Colleen M, Marnett, Lawrence J, Lindsley, Craig W, Ekstrom, Leeland B, Bentley, Alan R, Bernard, Gordon R, Hong, Charles C, Denny, Joshua C
Format:	Artikel
Sprache:	eng
Schlagworte:	Business law Data processing Databases, Genetic Deoxyribonucleic acid DNA Drug Design Drug development Drug discovery Drug Repositioning - methods Electronic health records Electronic medical records Genetic Predisposition to Disease - genetics Genetics Genome, Human - genetics Humans Indication Innovations Pharmacogenomic Testing - methods Precision Medicine - methods
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!